ENTX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 23:00):

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs...

Stats
Dzisiejszy wolumen	229 511
Średni wolumen	256 313
Kapitalizacja rynkowa	84.80M
EPS	$0 ( 2024-05-03 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.03
ATR14	$0.0170 (0.71%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Yaacov-garbeli Dana	Buy	130 000	Stock Option (right to buy)
2024-04-19	Yaacov-garbeli Dana	Buy	30 151	Ordinary Shares, par value NIS 0.0000769 per share
2024-04-19	Galitzer Hillel	Buy	130 000	Stock Option (right to buy)
2024-04-19	Galitzer Hillel	Buy	30 151	Ordinary Shares, par value NIS 0.0000769 per share
2024-01-12	Taitel Haya	Buy	9 500	Ordinary Shares, par value NIS 0.0000769 per share

INSIDER POWER
100.00
Last 93 transactions
Buy: 4 653 836 \| Sell: 4 161 674

Wolumen Korelacja

Długi: 0.39 (neutral)

Krótki: 0.94 (very strong)

Signal:(71.633) Expect same movement, but be aware

Entera Bio Ltd Korelacja

10 Najbardziej pozytywne korelacje
XBIT	0.947
PPC	0.941
SWAV	0.941
INCR	0.941
PRIM	0.938
TCOM	0.937
OCGN	0.936
SIMO	0.935
KAII	0.935
LGACU	0.935

10 Najbardziej negatywne korelacje
HCDIP	-0.947
SPTN	-0.928
AKTX	-0.926
PEAR	-0.924
AGRX	-0.919
VORB	-0.919
TTEC	-0.918
FAIL	-0.916
PRTS	-0.915
HTLD	-0.914

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Entera Bio Ltd Korelacja - Waluta/Towar

-0.38
( neutral )

-0.28
( neutral )

0.00
( neutral )

-0.03
( neutral )

0.02
( neutral )

0.16
( neutral )

Entera Bio Ltd Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2023
Przychody:	$0
Zysk brutto:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2022
Przychody:	$134 000
Zysk brutto:	$33 000.00 (24.63 %)
EPS:	$-0.450

FY	2021
Przychody:	$571 000
Zysk brutto:	$198 000 (34.68 %)
EPS:	$0.425

Financial Reports:

No articles found.

Entera Bio Ltd

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.